Linking Biophysical Functions of Microbicides to User Perception & Acceptability
将杀菌剂的生物物理功能与用户感知联系起来
基本信息
- 批准号:7684100
- 负责人:
- 金额:$ 43.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-28 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAddressBehavioralBiologicalCharacteristicsCognitiveDevelopmentDimensionsDrug FormulationsExtravasationFeasibility StudiesFutureGelGoalsHumanInterviewJointsKnowledgeLeadLinkLiquid substanceMeasurableMeasurementMeasuresMethodologyModelingPerceptionPerformancePhasePropertyPsychometricsResearchResearch PersonnelScienceScientistSpecific qualifier valueSumSystemTechnologyTissuesVaginaVaginal GelWorkbasebehavior measurementdesignexperiencefight againstinnovationmicrobicidemultidisciplinarynovelpandemic diseasepathogenpleasurepre-clinicalpreclinical studyprototyperesearch and developmentsuccesstoolvaginal microbicide
项目摘要
DESCRIPTION (provided by applicant): This project directly addresses RFA-AI-06-005 request for technologies, strategies or models that contribute to new and more efficient ways of assessing and predicting microbicide acceptability within the preclinical framework of formulation development. Achieving this goal requires integration of behavioral with biophysical determinants of acceptability parameters. This project analyzes correspondence of cognitive and behavioral aspects of user ratings of microbicide characteristics and activity, with biophysical microbicide properties governing vaginal distribution/retention ("deployment") and hypothesized to correlate with human perceptions of microbicide use. During the R21 project, qualitative interviews, item development strategies and cognitive interviews will enable behavioral investigators to develop a user rating scale for use within the framework of preclinical feasibility studies of candidate microbicides. In parallel, formulation scientists will compute measures of biophysical functioning of 2 current over-the-counter vaginal gels, hypothesized to correlate with the behavioral constructs. Once it is shown that the behavioral tool (i.e., scale) has good psychometric characteristics, relationships between user rating measures and biophysical measures will be evaluated. Correspondence between what users can perceive/evaluate with respect to their experiences using a gel, and what biophysical properties/analysis can predict with respect to these perceptions and user ratings, will be delineated. The project goal is to demonstrate that these two measurement systems can be employed synergistically, toward optimization of 1) microbicide biophysical properties governing effective deployment and biofunctionality, and 2) user ratings of application- and vehicle-associated acceptability. In the R33 these measurement systems will be further evaluated and validated using novel GRAS gel formulations. Finally, a statistical framework that initiates prediction of user ratings of gels will be developed. The microbicide field's ability to co-determine microbicide function and acceptability will dramatically increase its ability to conceive and create optimal formulations in preclinical studies. By linking user ratings with biophysical properties, the resulting behavioral tool (scale) will better inform the preclinical microbicide pipeline, enabling products to be tailored to future users with greater certainty. In sum, this work will contribute methodology leading to rational design of microbicide formulations that co-optimize vaginal distribution and retention with user acceptability.
描述(由申请人提供):该项目直接解决RFA-AI-06-005要求在配方开发的临床前框架内评估和预测微生物可接受性的新的,更有效的方法的技术,策略或模型。实现此目标需要将行为与可接受性参数的生物物理决定因素整合在一起。该项目分析了微生物特征和活性的用户评分的认知和行为方面的对应关系,生物物理菌糖的特性管理着阴道分布/保留率(“部署”),并假定与人类对菌心使用的看法相关。在R21项目中,定性访谈,项目开发策略和认知访谈将使行为研究人员能够开发一个用户评级量表,以在候选杀菌剂的临床前可行性研究框架内使用。同时,配方科学家将计算2种当前非处方阴道凝胶的生物物理功能的度量,假设与行为结构相关。一旦表明行为工具(即比例尺)具有良好的心理测量特征,将评估用户评分度量与生物物理措施之间的关系。用户可以使用凝胶对自己的经验感知/评估的对应关系,以及哪些生物物理属性/分析可以预测这些感知和用户评分的方法。项目的目标是证明这两个测量系统可以协同使用,以优化1)基于有效部署和生物功能的微生物生物物理特性,以及2)应用程序和车辆相关可接受性的用户评分。在R33中,将使用新型的GRAS凝胶配方对这些测量系统进行进一步评估和验证。最后,将开发一个启动凝胶用户评分预测的统计框架。微生物领域共同确定性微生物功能和可接受性的能力将大大提高其在临床前研究中的受孕和创造最佳制剂的能力。通过将用户评分与生物物理属性联系起来,所得的行为工具(比例)将更好地告知临床前微生物管道,从而使产品能够更确定地为未来的用户量身定制。总而言之,这项工作将有助于方法,从而导致合理设计菌皮制剂,从而将阴道分布和保留率与用户的可接受性合作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kate M Guthrie其他文献
Kate M Guthrie的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kate M Guthrie', 18)}}的其他基金
Advancing Reproductive Health: Qualitative Methods & Interdisciplinary Mentorship
促进生殖健康:定性方法
- 批准号:
8240777 - 财政年份:2012
- 资助金额:
$ 43.88万 - 项目类别:
Advancing Reproductive Health: Qualitative Methods & Interdisciplinary Mentorship
促进生殖健康:定性方法
- 批准号:
8823641 - 财政年份:2012
- 资助金额:
$ 43.88万 - 项目类别:
Advancing Reproductive Health: Qualitative Methods & Interdisciplinary Mentorship
促进生殖健康:定性方法
- 批准号:
8637097 - 财政年份:2012
- 资助金额:
$ 43.88万 - 项目类别:
Advancing Reproductive Health: Qualitative Methods & Interdisciplinary Mentorship
促进生殖健康:定性方法
- 批准号:
8451362 - 财政年份:2012
- 资助金额:
$ 43.88万 - 项目类别:
Evaluating User Perceptions and Experience of Dual Compartment Microbicide Form.
评估用户对双室杀菌剂形式的看法和体验。
- 批准号:
8404977 - 财政年份:2012
- 资助金额:
$ 43.88万 - 项目类别:
Preclinical User Accptability Studies Long Acting Vaginal Gels, Intravaginal Ring
长效阴道凝胶、阴道环的临床前用户可接受性研究
- 批准号:
7418070 - 财政年份:2008
- 资助金额:
$ 43.88万 - 项目类别:
Linking Biophysical Functions of Microbicides to User Perception & Acceptability
将杀菌剂的生物物理功能与用户感知联系起来
- 批准号:
7513361 - 财政年份:2006
- 资助金额:
$ 43.88万 - 项目类别:
Linking Biophysical Functions of Microbicides to User Perception & Acceptability
将杀菌剂的生物物理功能与用户感知联系起来
- 批准号:
7921125 - 财政年份:2006
- 资助金额:
$ 43.88万 - 项目类别:
Linking Biophysical Functions of Microbicides to User Perception & Acceptability
将杀菌剂的生物物理功能与用户感知联系起来
- 批准号:
7932824 - 财政年份:2006
- 资助金额:
$ 43.88万 - 项目类别:
Evaluating User Perceptions and Experience of Dual Compartment Microbicide Form.
评估用户对双室杀菌剂形式的看法和体验。
- 批准号:
8699501 - 财政年份:
- 资助金额:
$ 43.88万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Yuva Sath: A peer-led intervention to support substance use treatment and HIV prevention among young people who inject drugs in India
Yuva Sath:一项由同伴主导的干预措施,旨在支持印度注射吸毒年轻人的药物滥用治疗和艾滋病毒预防
- 批准号:
10698376 - 财政年份:2023
- 资助金额:
$ 43.88万 - 项目类别:
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)Research Core - Methods
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686544 - 财政年份:2023
- 资助金额:
$ 43.88万 - 项目类别:
Adapting mHealth interventions to improve self-management of HIV and substance use among emerging adults in Zambia
采用移动医疗干预措施,改善赞比亚新兴成年人对艾滋病毒和药物滥用的自我管理
- 批准号:
10813460 - 财政年份:2023
- 资助金额:
$ 43.88万 - 项目类别:
Intervening with Haitian Immigrants in the U.S. to Improve HIV Outcomes
对美国的海地移民进行干预以改善艾滋病毒感染结果
- 批准号:
10700451 - 财政年份:2023
- 资助金额:
$ 43.88万 - 项目类别:
Testing the Efficacy of Safe South Africa: An Intervention to Prevent HIV Risk and Interpersonal Violence Among Adolescent Boys
测试安全南非的功效:预防青春期男孩艾滋病毒风险和人际暴力的干预措施
- 批准号:
10700232 - 财政年份:2023
- 资助金额:
$ 43.88万 - 项目类别: